Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.298 USD | -0.13% | -82.67% | -87.37% |
05-07 | Capital One Downgrades GlycoMimetics to Equalweight, Price Target at $0.50 | MT |
05-06 | Sector Update: Health Care Stocks Higher in Late Afternoon Trading | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.37% | 19.23M | |
+2.97% | 108B | |
+10.21% | 105B | |
+1.57% | 23.46B | |
-12.77% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.50% | 17.19B | |
+6.00% | 13.99B | |
+37.20% | 12.53B |
- Stock Market
- Equities
- GLYC Stock
- News GlycoMimetics, Inc.
- GlycoMimetics Says FDA Approves Time-Based Analysis of Overall Survival in Phase 3 Acute Myeloid Leukemia Study